Related Experiment Videos
Can clinical trials in rheumatology be improved?
1Arthritis and Rheumatism Council Epidemiology Unit, University of Manchester, UK.
Current Opinion in Rheumatology
|April 1, 1991
Summary
Improving clinical trial design and reporting is crucial for arthritis treatment evaluation. Key recommendations include stricter result interpretation, "intention to treat" analysis, and standardized reporting of baseline data and outcomes.
Area of Science:
- Rheumatology
- Clinical Trial Methodology
Background:
- Clinical trials are essential for evaluating arthritis treatments.
- Current trial practices face challenges in patient compliance, size, endpoints, and reporting.
Purpose of the Study:
- To review major problems in clinical trial design, analysis, and reporting for arthritis.
- To highlight solutions for improving the reliability and comparability of clinical trial outcomes.
Main Methods:
- Literature review focusing on common issues in clinical trial methodology.
- Analysis of proposed improvements for trial interpretation and standardization.
Main Results:
- Identified key issues: patient compliance, trial size, inadequate endpoints, and insufficient reporting.
- Emphasized the need for stringent result interpretation and "intention to treat" analysis.
- Advocated for standardization in reporting baseline data, outcome measures, and statistical analyses.
Conclusions:
- Implementing standardized practices and rigorous interpretation will enhance clinical trial comparability.
- These improvements increase the likelihood of obtaining significant and reliable results for arthritis treatments.